These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38492744)

  • 1. PD-1 regulates ILC3-driven intestinal immunity and homeostasis.
    Jacquelot N; Xiong L; Cao WHJ; Huang Q; Yu H; Sayad A; Anttila CJA; Baldwin TM; Hickey PF; Amann-Zalcenstein D; Ohashi PS; Nutt SL; Belz GT; Seillet C
    Mucosal Immunol; 2024 Jun; 17(3):371-386. PubMed ID: 38492744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OLFM4 modulates intestinal inflammation by promoting IL-22
    Xing Z; Li X; He J; Chen Y; Zhu L; Zhang X; Huang Z; Tang J; Guo Y; He Y
    Commun Biol; 2024 Jul; 7(1):914. PubMed ID: 39075283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCR
    Mikami Y; Scarno G; Zitti B; Shih HY; Kanno Y; Santoni A; O'Shea JJ; Sciumè G
    Eur J Immunol; 2018 Jul; 48(7):1174-1180. PubMed ID: 29524223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis.
    Poholek CH; Dulson SJ; Zajac AJ; Harrington LE
    Immunohorizons; 2019 Jun; 3(6):194-202. PubMed ID: 31356165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity.
    Chun E; Lavoie S; Fonseca-Pereira D; Bae S; Michaud M; Hoveyda HR; Fraser GL; Gallini Comeau CA; Glickman JN; Fuller MH; Layden BT; Garrett WS
    Immunity; 2019 Nov; 51(5):871-884.e6. PubMed ID: 31628054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin alleviates ulcerative colitis by restoring the balance of NCR
    Xie X; Zhao M; Huang S; Li P; Chen P; Luo X; Wang Q; Pan Z; Li X; Chen J; Chen B; Zhou L
    Int Immunopharmacol; 2022 Nov; 112():109251. PubMed ID: 36182875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan metabolites relieve intestinal
    Peng Z; Zhang J; Zhang M; Yin L; Zhou Z; Lv C; Wang Z; Tang J
    Food Funct; 2024 May; 15(10):5364-5381. PubMed ID: 38639049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dahuang Mudan decoction repairs intestinal barrier in chronic colitic mice by regulating the function of ILC3.
    Huang S; Wang X; Xie X; Su Y; Pan Z; Li Y; Liang J; Zhang M; Pan S; Xu B; Li L; Chen J; Luo X; Zhou L
    J Ethnopharmacol; 2022 Dec; 299():115652. PubMed ID: 36038092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial-cell-derived neuroregulators control type 3 innate lymphoid cells and gut defence.
    Ibiza S; García-Cassani B; Ribeiro H; Carvalho T; Almeida L; Marques R; Misic AM; Bartow-McKenney C; Larson DM; Pavan WJ; Eberl G; Grice EA; Veiga-Fernandes H
    Nature; 2016 Jul; 535(7612):440-443. PubMed ID: 27409807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 receptor agonists alleviate colonic inflammation by modulating intestinal microbiota and the function of group 3 innate lymphoid cells.
    Sun H; Shu J; Tang J; Li Y; Qiu J; Ding Z; Xuan B; Chen M; Gan C; Lin J; Qiu J; Sheng H; Wang C
    Immunology; 2024 Jul; 172(3):451-468. PubMed ID: 38544428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial Sphingolipids Exacerbate Colitis by Inhibiting ILC3-derived IL-22 Production.
    Bao B; Wang Y; Boudreau P; Song X; Wu M; Chen X; Patik I; Tang Y; Ouahed J; Ringel A; Barends J; Wu C; Balskus E; Thiagarajah J; Liu J; Wessels MR; Lencer WI; Kasper DL; An D; Horwitz BH; Snapper SB
    Cell Mol Gastroenterol Hepatol; 2024; 18(2):101350. PubMed ID: 38704148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
    Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
    Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ILC3 function as a double-edged sword in inflammatory bowel diseases.
    Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F
    Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Intestinal ILC3 for the Treatment of Type 1 Diabetes.
    Stojanović I; Saksida T; Miljković Đ; Pejnović N
    Front Immunol; 2021; 12():653560. PubMed ID: 34149694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementarity and redundancy of IL-22-producing innate lymphoid cells.
    Rankin LC; Girard-Madoux MJ; Seillet C; Mielke LA; Kerdiles Y; Fenis A; Wieduwild E; Putoczki T; Mondot S; Lantz O; Demon D; Papenfuss AT; Smyth GK; Lamkanfi M; Carotta S; Renauld JC; Shi W; Carpentier S; Soos T; Arendt C; Ugolini S; Huntington ND; Belz GT; Vivier E
    Nat Immunol; 2016 Feb; 17(2):179-86. PubMed ID: 26595889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bi-directional signaling between the intestinal epithelium and type-3 innate lymphoid cells regulates secretory dynamics and interleukin-22.
    Read E; Peña-Cearra A; Coman D; Jowett GM; Chung MWH; Coales I; Syntaka S; Finlay RE; Tachó-Piñot R; van Der Post S; Naizi U; Roberts LB; Hepworth MR; Curtis MA; Neves JF
    Mucosal Immunol; 2024 Feb; 17(1):1-12. PubMed ID: 37952849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal CXCR6
    Liang Z; Tang Z; Zhu C; Li F; Chen S; Han X; Zheng R; Hu X; Lin R; Pei Q; Yin C; Wang J; Tang C; Cao N; Zhao J; Wang R; Li X; Luo N; Wen Q; Yu J; Li J; Xia X; Zheng X; Wang X; Huang N; Zhong Z; Mo C; Chen P; Wang Y; Fan J; Guo Y; Zhong H; Liu J; Peng Z; Mao H; Shi GP; Bonventre JV; Chen W; Zhou Y
    Immunity; 2024 Jun; 57(6):1306-1323.e8. PubMed ID: 38815582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22.
    Longman RS; Diehl GE; Victorio DA; Huh JR; Galan C; Miraldi ER; Swaminath A; Bonneau R; Scherl EJ; Littman DR
    J Exp Med; 2014 Jul; 211(8):1571-83. PubMed ID: 25024136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity.
    Giacomin PR; Moy RH; Noti M; Osborne LC; Siracusa MC; Alenghat T; Liu B; McCorkell KA; Troy AE; Rak GD; Hu Y; May MJ; Ma HL; Fouser LA; Sonnenberg GF; Artis D
    J Exp Med; 2015 Sep; 212(10):1513-28. PubMed ID: 26371187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation.
    Bhatt B; Zeng P; Zhu H; Sivaprakasam S; Li S; Xiao H; Dong L; Shiao P; Kolhe R; Patel N; Li H; Levy-Bercowski D; Ganapathy V; Singh N
    J Immunol; 2018 Apr; 200(8):2905-2914. PubMed ID: 29514953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.